Lucid Diagnostics, Inc. (LUCD)
1.365
-0.02
(-1.09%)
USD |
NASDAQ |
Feb 20, 16:00
1.36
0.00 (0.00%)
After-Hours: 18:45
Lucid Diagnostics Profit Margin (Quarterly) : -858.5% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| PAVmed, Inc. | -120.2K% |
| Celldex Therapeutics, Inc. | -- |
| Plus Therapeutics, Inc. | -316.6% |
| Atossa Therapeutics, Inc. | -- |
| Abeona Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -665.2% |
| Return on Assets | -149.7% |
| Return on Invested Capital | -164.9% |
| Gross Profit Margin (Quarterly) | -58.30% |
| Operating Margin (Quarterly) | -971.0% |
| Return on Net Operating Assets | -977.1% |